000 | 01810 a2200469 4500 | ||
---|---|---|---|
005 | 20250517133721.0 | ||
264 | 0 | _c20170512 | |
008 | 201705s 0 0 eng d | ||
022 | _a1878-1705 | ||
024 | 7 |
_a10.1016/j.intimp.2017.01.002 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAbo-Elmatty, Dina M | |
245 | 0 | 0 |
_aMetformin enhancing the antitumor efficacy of carboplatin against Ehrlich solid carcinoma grown in diabetic mice: Effect on IGF-1 and tumoral expression of IGF-1 receptors. _h[electronic resource] |
260 |
_bInternational immunopharmacology _cMar 2017 |
||
300 |
_a72-86 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aCarboplatin _xtherapeutic use |
650 | 0 | 4 |
_aCarcinoma, Ehrlich Tumor _xcomplications |
650 | 0 | 4 |
_aCaspase 3 _xmetabolism |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xcomplications |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xmetabolism |
650 | 0 | 4 |
_aIntercellular Signaling Peptides and Proteins _xmetabolism |
650 | 0 | 4 |
_aMetformin _xtherapeutic use |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred Strains |
650 | 0 | 4 |
_aNeovascularization, Pathologic _xcomplications |
650 | 0 | 4 |
_aReceptor, IGF Type 1 _xmetabolism |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xmetabolism |
700 | 1 | _aAhmed, Eman A | |
700 | 1 | _aTawfik, Mona K | |
700 | 1 | _aHelmy, Seham A | |
773 | 0 |
_tInternational immunopharmacology _gvol. 44 _gp. 72-86 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.intimp.2017.01.002 _zAvailable from publisher's website |
999 |
_c26785537 _d26785537 |